- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cytosorbents Crp (CTSO)
Cytosorbents Crp stock price live, this page displays NASDAQ CTSO stock exchange data. View the CTSO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cytosorbents Crp real time stock price chart below.
What Is the Cytosorbents Crp Stock Price Today?
The Cytosorbents Crp stock price today is 0.910.
What Is the Stock Symbol for Cytosorbents Crp?
The stock symbol for Cytosorbents Crp is "CTSO."
What Stock Exchange Does Cytosorbents Crp Trade On?
Cytosorbents Crp is listed and trades on the NASDAQ stock exchange.
Is Cytosorbents Crp a Good Stock to Buy?
Determining whether Cytosorbents Crp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTSO quote. (ISIN: US23283X2062)
What Is the Cytosorbents Crp Stock Price Today?
The Cytosorbents Crp stock price today is 0.910.
What Is the Stock Symbol for Cytosorbents Crp?
The stock symbol for Cytosorbents Crp is "CTSO."
What Stock Exchange Does Cytosorbents Crp Trade On?
Cytosorbents Crp is listed and trades on the NASDAQ stock exchange.
Is Cytosorbents Crp a Good Stock to Buy?
Determining whether Cytosorbents Crp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTSO quote. (ISIN: US23283X2062)
NASDAQ
Currency in USD
0.910
-0.032(-3.40%)
Closed·
After Hours
0.900-0.010(-1.10%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.910
1.000
52 wk Range
0.710
1.610
CTSO Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 6 days
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9101.000
52 wk Range
0.7101.610
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CTSO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
5.000
Upside
+449.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cytosorbents Crp Company Profile
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. The company’s flagship product is CytoSorb, an extracorporeal blood purification cartridge for the treatment of massive inflammation, organ failure, cardiothoracic surgery to remove antithrombotic drugs and inflammatory mediators that can lead to postoperative complications, such as severe bleeding, shock, failure to wean from mechanical ventilation, sepsis, and multiple organ failure; DrugSorb-ATR, an antithrombotic removal system; VetResQ, a broad-spectrum blood purification adsorber for the treatment of septic shock, toxic shock syndrome, toxin-mediated diseases, pancreatitis, trauma, liver failure, heat stroke, and lung injury in animals; PuriFi, an advanced hemoperfusion pump for blood purification therapies; and ECOS-300CY, an ex vivo organ perfusion system to preserve or improve the health and quality of harvested solid organs to be transplanted. In addition, it develops HemoDefend-BGA, a blood purification technology platform to reduce anti-A and anti-B antibodies in plasma and whole blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
Cytosorbents Crp Earnings Call Summary for Q1/2025
- CytoSorbents Q1 2025 EPS -$0.06, missing -$0.05 forecast; revenue $8.7M, below $10.82M expected; stock dips 7.11%, recovers 2.29% after-hours
- Operating loss reduced 17% YoY to $3.9M; gross margin strong at 71%; total cash $13.1M as of March 31, 2025
- Company aims for near breakeven by end of 2025; preparing controlled market intro of DrugSorb ATR device; regulatory decisions expected in US, Canada
- CEO emphasizes focus on improving clinical outcomes; analysts forecast 12% revenue growth for FY2025 but no profitability expected
- Challenges include FDA approval for DrugSorb ATR, revenue decline in competitive market, potential delays in expansion and product launches
Last Updated: 05/15/2025, 05:24 AM
Read Full TranscriptCompare CTSO to Peers and Sector
Metrics to compare | CTSO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCTSOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.7x | −4.6x | −0.5x | |
PEG Ratio | −0.07 | −0.30 | 0.00 | |
Price/Book | 4.1x | 3.2x | 2.6x | |
Price / LTM Sales | 1.7x | 3.4x | 3.2x | |
Upside (Analyst Target) | 337.6% | 39.4% | 41.2% | |
Fair Value Upside | Unlock | 5.2% | 6.2% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.000
(+449.45% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
8.70M / 10.82M
People Also Watch
FAQ
What Is the Cytosorbents Crp (CTSO) Stock Price Today?
The Cytosorbents Crp stock price today is 0.91
What Stock Exchange Does Cytosorbents Crp Trade On?
Cytosorbents Crp is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Cytosorbents Crp?
The stock symbol for Cytosorbents Crp is "CTSO."
What Is the Cytosorbents Crp Market Cap?
As of today, Cytosorbents Crp market cap is 59.48M.
What Is Cytosorbents Crp's Earnings Per Share (TTM)?
The Cytosorbents Crp EPS (TTM) is -0.29.
When Is the Next Cytosorbents Crp Earnings Date?
Cytosorbents Crp will release its next earnings report on Aug 04, 2025.
From a Technical Analysis Perspective, Is CTSO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cytosorbents Crp Stock Split?
Cytosorbents Crp has split 1 times.
How Many Employees Does Cytosorbents Crp Have?
Cytosorbents Crp has 149 employees.
What is the current trading status of Cytosorbents Crp (CTSO)?
As of Jul 29, 2025, Cytosorbents Crp (CTSO) is trading at a price of 0.91, with a previous close of 0.94. The stock has fluctuated within a day range of 0.91 to 1.00, while its 52-week range spans from 0.71 to 1.61.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.